Smith M - Search Results

1

High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.

Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ. Bartha R, et al. Among authors: smith m. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):786-93. doi: 10.1016/j.pnpbp.2007.12.011. Epub 2007 Dec 23. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18252268 Clinical Trial.

2

Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R; Alzheimer's Disease Neuroimaging Initiative. Nestor SM, et al. Among authors: smith m. Brain. 2008 Sep;131(Pt 9):2443-54. doi: 10.1093/brain/awn146. Epub 2008 Jul 11. Brain. 2008. PMID: 18669512 Free PMC article.

3

Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.

Penner J, Rupsingh R, Smith M, Wells JL, Borrie MJ, Bartha R. Penner J, et al. Among authors: smith m. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):104-10. doi: 10.1016/j.pnpbp.2009.10.007. Epub 2009 Oct 13. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 19833161 Clinical Trial.

4

Treatment effect size of memantine therapy in Alzheimer disease and vascular dementia.

Smith M, Wells J, Borrie M. Smith M, et al. Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3):133-7. doi: 10.1097/00002093-200607000-00002. Alzheimer Dis Assoc Disord. 2006. PMID: 16917181 Review.

5

Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease.

Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Esiri MM, et al. Among authors: smith mz, smith ad. Lancet. 1999 Sep 11;354(9182):919-20. doi: 10.1016/S0140-6736(99)02355-7. Lancet. 1999. PMID: 10489957

6

Coexisting pathologies in the brain: influence of vascular disease and Parkinson's disease on Alzheimer's pathology in the hippocampus.

Smith MZ, Nagy Z, Barnetson L, King EM, Esiri MM. Smith MZ, et al. Acta Neuropathol. 2000 Jul;100(1):87-94. doi: 10.1007/s004010051197. Acta Neuropathol. 2000. PMID: 10912925

7

Cell cycle-related protein expression in vascular dementia and Alzheimer's disease.

Smith MZ, Nagy Z, Esiri MM. Smith MZ, et al. Neurosci Lett. 1999 Aug 13;271(1):45-8. doi: 10.1016/s0304-3940(99)00509-1. Neurosci Lett. 1999. PMID: 10471210

8

Hyperhomocysteinaemia in Alzheimer's disease and expression of cell cycle markers in the brain.

Nagy ZS, Smith MZ, Esiri MM, Barnetson L, Smith AD. Nagy ZS, et al. Among authors: smith mz, smith ad. J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):565-6. doi: 10.1136/jnnp.69.4.565. J Neurol Neurosurg Psychiatry. 2000. PMID: 11183042 Free PMC article. No abstract available.

9

Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline.

Smith MZ, Esiri MM, Barnetson L, King E, Nagy Z. Smith MZ, et al. Dement Geriatr Cogn Disord. 2001 Jul-Aug;12(4):281-8. doi: 10.1159/000051270. Dement Geriatr Cogn Disord. 2001. PMID: 11351139

10

D₁ dopamine / mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression, and a conditioned place preference procedure: assessment of therapeutic index in male Sprague Dawley rats.

LaCourse H, Bennett L, Falstad A, Asmus F, Smith M, Davis R, Harrington K, Giuvelis D, King T, Stevenson GW. LaCourse H, et al. Among authors: smith m. Psychopharmacology (Berl). 2025 Jan 20. doi: 10.1007/s00213-025-06743-9. Online ahead of print. Psychopharmacology (Berl). 2025. PMID: 39832015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,676 results

Search Page

Filters